|
PARD6G expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.391400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.938800E-01 |
| Normal-vs-Stage2 |
3.407800E-01 |
| Normal-vs-Stage3 |
8.978200E-01 |
| Normal-vs-Stage4 |
2.496400E-01 |
| Stage1-vs-Stage2 |
5.372100E-02 |
| Stage1-vs-Stage3 |
4.474400E-01 |
| Stage1-vs-Stage4 |
1.552200E-02 |
| Stage2-vs-Stage3 |
2.904200E-01 |
| Stage2-vs-Stage4 |
8.482800E-01 |
| Stage3-vs-Stage4 |
1.758590E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.016600E-01 |
| Normal-vs-AfricanAmerican |
1.683380E-01 |
| Normal-vs-Asian |
1.416590E-01 |
| Caucasian-vs-AfricanAmerican |
5.865600E-02 |
| Caucasian-vs-Asian |
1.296400E-01 |
| AfricanAmerican-vs-Asian |
3.549000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.297400E-01 |
| Normal-vs-Female |
7.958300E-02 |
| Male-vs-Female |
4.05620000000217E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.506200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.664800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.105800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.535500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.008600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.562400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.900700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.271800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.916300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.277800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.010200E-01 |
| Normal-vs-Grade 2 |
2.810600E-01 |
| Normal-vs-Grade 3 |
7.307400E-01 |
| Normal-vs-Grade 4 |
6.019600E-02 |
| Grade 1-vs-Grade 2 |
6.472200E-01 |
| Grade 1-vs-Grade 3 |
2.105800E-01 |
| Grade 1-vs-Grade 4 |
2.582100E-02 |
| Grade 2-vs-Grade 3 |
4.364300E-02 |
| Grade 2-vs-Grade 4 |
4.043400E-04 |
| Grade 3-vs-Grade 4 |
6.277700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.456210E-03 |
| Normal-vs-ccB subtype |
7.962600E-03 |
| ccA subtype-vs-ccB subtype |
<1E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.700200E-01 |
| Normal-vs-N1 |
3.054400E-02 |
| N0-vs-N1 |
3.854100E-02 |
|
|
